Biomedical politics
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Washington, D.C. :
National Academy Press
1991.
|
| Edición: | 1st ed |
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820323406719 |
Tabla de Contenidos:
- Biomedical Politics
- Copyright
- Preface
- Acknowledgments
- Contents
- Introduction
- References
- Unproven AIDS Therapies: The Food and Drug Administration and DDI
- THE DRUG REGULATION PROCESS
- The Drug Approval Process Today
- Speeding Up the Process: The "Bush Initiative
- Prelicensing Availability
- PARALLEL TRACK
- PARALLEL TRACK: PROS AND CONS
- The Food and Drug Administration
- The Research Community
- The AIDS Activists
- Other Consumer Interests
- EARLY RELEASE OF DDI
- MOTIVATIONS
- Bristol-Myers
- The Food and Drug Administration
- The National Institutes of Health
- The Activists
- CONCLUSIONS
- NOTES
- REFERENCES
- Commentary
- LEON EISENBERG
- Commentary
- PETER F. CARPENTER
- A Political History of RU-486
- Introducing Contraceptives to the United States
- THE EARLY DEVELOPMENT OF RU-486
- COMMERCIAL INTEREST IN RU-486
- THE GROWING THREAT OF ANTI-ABORTION GROUPS
- CORPORATE PRESSURE FOR WITHDRAWAL
- THE RETURN OF RU-486
- THE CONTINUING OPPOSITION
- SUCCESS OF THE BOYCOTT THREAT
- THE FEMINIST AND MEDICAL COMMUNITY RESPONSE
- INTERNATIONAL RU-486 AVAILABILITY
- GETTING RU-486 TO THE UNITED STATES
- INDUSTRY CONSTRAINTS ON RU-486 DEVELOPMENT
- Market Share and Price
- FDA Review
- Product Liability
- Public Relations
- AMERICAN ACCESS TO RU-486 IN THE 1990S
- REFERENCES
- Commentary
- WILLIAM N. HUBBARD
- Commentary
- PETER F. CARPENTER
- The Human Genome Project: The Formation of Federal Policies in the United States, 1986-1990
- TECHNICAL AND SCIENTIFIC BACKGROUND
- ORIGINS OF DEDICATED GENOME RESEARCH PROGRAMS
- THE DEPARTMENT OF ENERGY PLAN
- THE SCIENTIFIC COMMUNITY RESPONDS
- CALLS FOR EVALUATION
- THE NATIONAL INSTITUTES OF HEALTH AND CONGRESS RESPOND
- THE PROJECT IS FUNDED
- SOCIAL ISSUES EMERGE
- STILL, ORGANIZATIONAL ISSUES
- CONCLUSIONS
- APPENDIX A.
- Where Was OSTP?
- APPENDIX B
- Can the Genome Project Keep Its Promises?
- APPENDIX C
- Is Cost Wobble a Serious Problem?
- APPENDIX D
- What Is "Technically Feasible" in the Policy Context?
- REFERENCES
- Commentary
- PAUL BERG
- Commentary
- ERNEST R. MAY
- Origins of the Medicare Kidney Disease Entitlement: The Social Security Amendments of 1972
- A HISTORICAL FOOTNOTE
- ANTECEDENTS TO THE 1972 LEGISLATION
- The Influence of the Gottschalk Report
- Setting the Legislative Stage
- THE SOCIAL SECURITY AMENDMENTS OF 1972, SECTION 299I
- The Legislative Process
- The Policy Context
- The Adoption of Section 299I
- Ways and Means: November and December 1971
- Senate Finance Committee: 1972
- The Joint House-Senate Conference Committee: 1972
- ESTIMATES OF COST
- SUMMARY AND CONCLUSIONS
- AFTERWORD
- APPENDIX
- Public Law 92-603, 92nd Congress, H.R. 1 October 30, 1972
- NOTES
- REFERENCES
- Commentary
- CARL W. GOTTSCHALK
- Commentary
- STANLEY JOEL REISER
- Deliberations of the Human Fetal Tissue Transplantation Research Panel
- BACKGROUND AND CONTEXT
- PROCESS
- THE MORAL STATUS OF THE FETUS AND THE MORALITY OF ABORTION
- COMPLICITY, COLLABORATION, AND COOPERATION IN MORAL EVIL
- INCREASE IN THE NUMBER OF ABORTIONS
- General Altruism
- Specific Altruism
- Incentives of Financial Gain
- SOCIETAL LEGITIMATION OF ABORTION DECISIONS AND PRACTICES
- DISPOSITIONAL AUTHORITY OVER FETAL REMAINS
- LIMITS ON DISCLOSURE OF INFORMATION AND DECISION MAKING
- OTHER ISSUES AND RECOMMENDATIONS
- OTHER DEVELOPMENTS AND PUBLIC POLICY RESPONSES
- CONCLUSION
- APPENDIX A
- APPENDIX B
- Human Fetal Tissue Transplantation Research Panel
- REFERENCES
- ADDITIONAL BIBLIOGRAPHY
- Commentary
- PATRICIA A. KING
- NOTES
- Commentary
- WALTER HARRELSON
- Asilomar and Recombinant DNA: The End of the Beginning.
- THE COMING OF AGE OF MOLECULAR BIOLOGY
- Structure of DNA
- Fruit Flies, Corn, and Molds
- The Need for Germs
- An International Frontier
- SETTING THE STAGE: THE EXPERIMENT AND ITS EFFECTS
- Critique
- The Encounter
- The "First" Asilomar Conference
- EcoRI
- Scientific Exchange and Scrutiny
- THE 1973 GORDON CONFERENCE ON NUCLEIC ACIDS
- THE ACADEMY'S TURN
- THE ASILOMAR CONFERENCE
- Monday, February 24-Opening Day
- Tuesday, February 25-Getting Down to Guidelines
- Wednesday, February 26-Dissonance and Lessons in the Law
- Thursday, February 27-The Final Hours
- CONCLUSION
- NOTES
- APPENDIX
- Participants in the International Conference on Recombinant DNA Molecules Asilomar Conference Center ...
- Organizing Committee
- Domestic Participants
- Foreign Participants
- Press Participants
- Commentary
- DOROTHY NELKIN
- Commentary
- PAUL SLOVIC
- THE NATURE OF PERCEPTION
- THE EFFECTS OF PERCEPTIONS
- REFERENCES
- Conclusions
- THEMES OF DECISION MAKING
- Pluralism and Democracy
- Incrementalism
- Chance, Fate, and Politics
- Precedents and the Slippery Slope
- Politics, Expertise, and Process
- QUESTIONS FOR RESEARCH
- How and Why Does an Issue Become Public, and What Is the Proper Response?
- What Are the Roles of Science Versus the Public in Risk Recognition, Perception, Assessment, and Management?
- What Are the Role and Impact of the Media in Publicizing and Defining the Debate?
- How Can We Evaluate and Predict the Impact of Single-Issue Politics?
- How Have the Ground Rules and Institutions Changed in Biomedical Decision Making?
- How Can Costs of Research and Treatment Be Estimated to Diminish Future Conflicts?
- When Is Consensual Decision Making the Most Desirable Approach?
- What Are the Domains of Politics and Science? Where Do They Overlap? What Is the Role of Expertise?.
- Who Represents the Public?
- QUESTIONS FOR POLICY MAKERS
- REFERENCES
- Appendixes
- Appendix A The Public and the Expert in Biomedical Policy Controversies
- QUESTIONING THE EXPERTS: THE CHALLENGE FROM LAYMEN
- QUESTIONING THE EXPERTS: THE CHALLENGE FROM OFFICIALDOM
- THE EXPERT'S JOURNEY INTO PUBLIC DOMAIN
- CONCLUSION
- REFERENCES
- Appendix B Biographical Notes on Authors and Commentators
- Index.
